Tapio Nousiainen
Department of Medicine
Kuopio University Hospital and University of Kuopio
Finland
Name/email consistency: high
- Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction. Nousiainen, T., Vanninen, E., Jantunen, E., Puustinen, J., Remes, J., Rantala, A., Vuolteenaho, O., Hartikainen, J. J. Intern. Med. (2002)
- Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients. Nousiainen, T., Jantunen, E., Vanninen, E., Hartikainen, J. Br. J. Cancer (2002)
- Concomitant impairment of left ventricular systolic and diastolic function during doxorubicin therapy: a prospective radionuclide ventriculographic and echocardiographic study. Nousiainen, T., Vanninen, E., Jantunen, E., Puustinen, J., Remes, J., Rantala, A., Hartikainen, J. Leuk. Lymphoma (2002)
- Comparison of echocardiography and radionuclide ventriculography in the follow-up of left ventricular systolic function in adult lymphoma patients during doxorubicin therapy. Nousiainen, T., Vanninen, E., Jantunen, E., Puustinen, J., Remes, J., Rantala, A., Hartikainen, J. J. Intern. Med. (2001)
- Neuroendocrine changes during the evolution of doxorubicin-induced left ventricular dysfunction in adult lymphoma patients. Nousiainen, T., Vanninen, E., Jantunen, E., Remes, J., Ritanen, E., Vuolteenaho, O., Hartikainen, J. Clin. Sci. (2001)
- Natriuretic peptides as markers of cardiotoxicity during doxorubicin treatment for non-Hodgkin's lymphoma. Nousiainen, T., Jantunen, E., Vanninen, E., Remes, J., Vuolteenaho, O., Hartikainen, J. Eur. J. Haematol. (1999)
- QT dispersion and late potentials during doxorubicin therapy for non-Hodgkin's lymphoma. Nousiainen, T., Vanninen, E., Rantala, A., Jantunen, E., Hartikainen, J. J. Intern. Med. (1999)
- Acute neurohumoral and cardiovascular effects of idarubicin in leukemia patients. Nousiainen, T., Jantunen, E., Vanninen, E., Remes, J., Puustinen, J., Rantala, A., Vuolteenaho, O., Hartikainen, J. Eur. J. Haematol. (1998)
